CN103462889A - 一种布洛芬混悬液及其制备方法 - Google Patents
一种布洛芬混悬液及其制备方法 Download PDFInfo
- Publication number
- CN103462889A CN103462889A CN2013103479850A CN201310347985A CN103462889A CN 103462889 A CN103462889 A CN 103462889A CN 2013103479850 A CN2013103479850 A CN 2013103479850A CN 201310347985 A CN201310347985 A CN 201310347985A CN 103462889 A CN103462889 A CN 103462889A
- Authority
- CN
- China
- Prior art keywords
- ibuprofen
- suspension
- radix
- preparation
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title claims abstract description 52
- 229960001680 ibuprofen Drugs 0.000 title claims abstract description 51
- 239000000725 suspension Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 206010037660 Pyrexia Diseases 0.000 claims abstract description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- 235000010489 acacia gum Nutrition 0.000 claims description 12
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 235000012730 carminic acid Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 8
- 229920000053 polysorbate 80 Polymers 0.000 claims description 8
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 8
- 239000004299 sodium benzoate Substances 0.000 claims description 8
- 235000010234 sodium benzoate Nutrition 0.000 claims description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- 239000005720 sucrose Substances 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 44
- 229940079593 drug Drugs 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 5
- 206010057190 Respiratory tract infections Diseases 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 230000036760 body temperature Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 229960001138 acetylsalicylic acid Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 230000001754 anti-pyretic effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 229960005489 paracetamol Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 238000011725 BALB/c mouse Methods 0.000 description 2
- 206010011469 Crying Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 206010039740 Screaming Diseases 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000006793 Artemisia stelleriana Nutrition 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 101100027969 Caenorhabditis elegans old-1 gene Proteins 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000264063 Lethrinus rubrioperculatus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 235000006413 coastal sagewort Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940120889 dipyrone Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Abstract
Description
组别 | 小鼠数目(只) | 扭体次数(30min) |
生理盐水组 | 20 | 32.7 |
实施例1 | 20 | 12.3 |
实施例2 | 20 | 7.1 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310347985.0A CN103462889B (zh) | 2013-08-09 | 2013-08-09 | 一种布洛芬混悬液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310347985.0A CN103462889B (zh) | 2013-08-09 | 2013-08-09 | 一种布洛芬混悬液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103462889A true CN103462889A (zh) | 2013-12-25 |
CN103462889B CN103462889B (zh) | 2014-12-17 |
Family
ID=49788093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310347985.0A Active CN103462889B (zh) | 2013-08-09 | 2013-08-09 | 一种布洛芬混悬液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103462889B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106727303A (zh) * | 2017-01-03 | 2017-05-31 | 天大药业(珠海)有限公司 | 布洛芬口服混悬液及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682896A (zh) * | 2005-03-10 | 2005-10-19 | 陕西方舟制药有限公司 | 治疗小儿上呼吸道炎的药物及其制备方法 |
CN1788728A (zh) * | 2004-12-16 | 2006-06-21 | 沈阳市恒泰科技开发有限公司 | 复方抗感冒布洛芬口服液、混悬剂 |
CN101347411A (zh) * | 2008-08-29 | 2009-01-21 | 扬州市三药制药有限公司 | 布洛芬混悬液及其制备方法 |
CN101584827A (zh) * | 2008-05-25 | 2009-11-25 | 杨洪青 | 一种治疗小儿感冒的中药 |
CN101912360A (zh) * | 2010-07-13 | 2010-12-15 | 山东达因海洋生物制药股份有限公司 | 布洛芬混悬液及其制备方法 |
-
2013
- 2013-08-09 CN CN201310347985.0A patent/CN103462889B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1788728A (zh) * | 2004-12-16 | 2006-06-21 | 沈阳市恒泰科技开发有限公司 | 复方抗感冒布洛芬口服液、混悬剂 |
CN1682896A (zh) * | 2005-03-10 | 2005-10-19 | 陕西方舟制药有限公司 | 治疗小儿上呼吸道炎的药物及其制备方法 |
CN101584827A (zh) * | 2008-05-25 | 2009-11-25 | 杨洪青 | 一种治疗小儿感冒的中药 |
CN101347411A (zh) * | 2008-08-29 | 2009-01-21 | 扬州市三药制药有限公司 | 布洛芬混悬液及其制备方法 |
CN101912360A (zh) * | 2010-07-13 | 2010-12-15 | 山东达因海洋生物制药股份有限公司 | 布洛芬混悬液及其制备方法 |
Non-Patent Citations (1)
Title |
---|
WWWATSYYCOM: "安童生布洛芬混悬液", 《HTTP://BAIKE.BAIDU.COM/HISTORY/29970106》, 7 May 2012 (2012-05-07), pages 1 - 2 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106727303A (zh) * | 2017-01-03 | 2017-05-31 | 天大药业(珠海)有限公司 | 布洛芬口服混悬液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103462889B (zh) | 2014-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432545B (zh) | 一种用于小儿退烧的药物及其制备方法 | |
CN105412858A (zh) | 一种糖浆及其制备方法 | |
CN102416144B (zh) | 治疗小儿惊风的中药 | |
CN104147063A (zh) | 一种复方小儿退热栓及其制备方法 | |
CN103495048A (zh) | 一种用于治疗小儿口舌生疮的中药组合物 | |
CN104147194B (zh) | 一种治疗慢性鼻窦炎的中药组合物 | |
CN103462889B (zh) | 一种布洛芬混悬液及其制备方法 | |
CN102836254A (zh) | 一种用于治疗鸡传染性法氏囊炎的药物组合物及其制备方法 | |
CN103142965A (zh) | 一种治疗寒饮型小儿支气管哮喘的中药制剂 | |
CN103405723B (zh) | 一种用于小儿反复呼吸道感染的药物组合物 | |
CN103622994A (zh) | 复方冰二黄软膏 | |
CN102552807A (zh) | 一种治疗风温型流感的中药及其制备方法与应用 | |
CN103028041B (zh) | 用于治疗儿童急性鼻窦炎的中药组合物及其制备方法 | |
CN103142964A (zh) | 一种治疗寒饮夹热型小儿支气管哮喘的中药制剂 | |
CN103071142A (zh) | 一种速效气管炎外用贴 | |
CN104383512A (zh) | 制备用于小儿退烧的药物制剂的方法 | |
CN104474514A (zh) | 一种用于小儿发烧的中成药物 | |
CN110251606B (zh) | 一种改善睡眠功效的中药组合物及制备方法 | |
CN102940697B (zh) | 治疗过敏性鼻炎和支气管哮喘的药物 | |
CN102641422B (zh) | 一种治疗急性荨麻疹的中成药 | |
CN102406913A (zh) | 一种治疗郁证的中药组合物 | |
CN105535626A (zh) | 用于联合抗涝药治疗肺结核的中药药物 | |
CN105311602A (zh) | 一种防治小儿哮喘的中药组合物 | |
CN102210782B (zh) | 治疗糖皮质激素依赖的复方中药及其应用 | |
CN104547983A (zh) | 一种治疗风寒性感冒的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG XIANGYU HEALTH PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LIN FANYOU Effective date: 20140710 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140710 Address after: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Applicant after: SHANDONG XIANGYU HEALTH PHARMACEUTICAL Co.,Ltd. Address before: 276023 Beijing road Shandong Linyi Province, Linyi City Economic Development Zone No. 30 Shandong Xiangyu Health Pharmaceutical Co. Ltd. Applicant before: Lin Fanyou |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: XIANGYU PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHANDONG XIANGYU HEALTH PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Patentee after: XIANGYU PHARMACEUTICAL Co.,Ltd. Address before: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Patentee before: SHANDONG XIANGYU HEALTH PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20221213 Address after: 276600 South Renhetang Pharmaceutical Co., Ltd., Xishou Road, Huaihai Road, Junan Economic Development Zone, Linyi City, Shandong Province Patentee after: RENHETANG PHARMACEUTICAL CO.,LTD. Address before: No. 30, Hangzhou Road, Linyi Economic and Technological Development Zone, Linyi, Shandong 276023 Patentee before: XIANGYU PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231010 Address after: 276000 No. 30, Xiangyu Road, economic and Technological Development Zone, Linyi City, Shandong Province Patentee after: XIANGYU PHARMACEUTICAL Co.,Ltd. Address before: 276600 South Renhetang Pharmaceutical Co., Ltd., Xishou Road, Huaihai Road, Junan Economic Development Zone, Linyi City, Shandong Province Patentee before: RENHETANG PHARMACEUTICAL CO.,LTD. |
|
TR01 | Transfer of patent right |